5-19
Thailand Renal Replacement Therapy Registration Outcome

Kearkiat Praditpornsilpa, Kriang Tungsanga
Division of Nephrology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand

 

Thailand Renal Replacement Therapy Registry has been initiated since 1997. The registry has been done by non-compulsory registration. However the registration process is part of national dialysis service accreditation. The data of the hemodialysis center, CAPD center and renal transplantation center will be registered to Thai Nephrology Society which include the dialysis center data and the patientユs data. During the last 10 years, the data were sent to Thai Nephrology Society by non-electronic TRT form annually.

At current status, there are 352 hemodialysis centers in Thailand. More than 40% of the hemodialysis centers are located in Bangkok. Most of the hemodialysis centers own by private sector. Compared to hemodialysis center, there are 59 CAPD centers and 29 institutes which perform renal transplantation. The growth of hemodialysis center has been increasing during the last 5 years due to the new reimbursement policy of hemodialysis procedure. Compared to hemodialysis, the number of CAPD patients is stable. The growth of renal transplantation patient is limited by the number of renal allograft donation. By analysis of the registry data, the point prevalence of alive renal replacement therapy (hemodialysis, CAPD and renal transplantation) was 243.29 per million populations and the incidence of new renal replacement therapy patient was 128.61 per million populations. Both prevalence and incidence of renal replacement therapy patients progressively increase during the last 5 years. We speculate that prevalence and incidence of renal replacement therapy patients by the Thailand Renal Replacement Therapy Registry are underestimated the actual prevalence and incidence of end stage renal disease patients. The access to the therapy which limit by the financial burden to the patients may cause the underestimation.

There are also limitation of the registry data cause by the non-real time data entry and the error which might happen by sending the non-electronic data. We plan to initiate the web-based renal replacement therapy registry which will provide more data namey: the anemia management and outcome, the vascular access management and outcome, the adequacy of the dialysis and outcome, the renal bone disease management and outcome. By having an electronic based data management system, we hope we can have more accuracy of data and base on the data, we can provide a better renal replacement therapy to our patients and may find strategy to optimize the renal replacement therapy service both medically and financially.

 

<back>